
Teonanácatl
Psilocybe mexicana, P. cubensis, P. semilanceata; teonanácatl, “flesh of the gods”
- Known today as
- Small mushrooms that turn blue where they are bruised.
- Kind
- Fungus
- Constituents
- psilocybin, psilocin
- Poisoning
- Psilocybin
- In other databases
- GBIF search · Wikidata search
Revised October 17, 2026: Checked against its sources, each read in full, in part, or in its abstract. Version 1, first published September 25, 2026.
Caution. Profoundly psychoactive; illegal in most places.
Teonanácatl: what was it used for?
Eaten in religious ceremonies in Mesoamerica before the conquest, a use that persisted after it.
Teonanácatl: what does modern science say?
In a phase 2 trial in treatment-resistant depression, a single 25 mg dose of psilocybin, but not 10 mg, lowered depression scores more than a 1 mg dose over three weeks, with adverse effects, and larger trials were called for; it remains a controlled drug in most countries.
The toxic dose and the poisoning
- Toxic dose
- In a controlled study, 30 mg per 70 kg brought perceptual changes, labile moods including anxiety, and mystical-type experiences; in mice an extract of P. semilanceata had an LD50 of about 324 mg/kg.
- Syndrome
- Psilocybin
The references for these lines are listed under Pharmacognosy, in Science. Doses are as the references give them, for description only; this is not medical advice. In a poisoning, call a poison centre.
Teonanácatl: what lore surrounds it?
The Spanish friar Bernardino de Sahagún wrote that the little mushrooms called teonanácatl made those who ate them see visions, that no more than two or three should be eaten, and that they were medicinal against fevers and gout. In 1957 R. Gordon Wasson described in Life magazine the ceremony of the Mazatec healer María Sabina, and in 1958 Albert Hofmann isolated psilocybin.
In Their Own Words
Safford quotes, in English, Sahagún's sixteenth-century account of Aztec feasts at which the first thing eaten was black mushrooms called nanacatl, which intoxicated and caused visions.
“The first thing eaten at the party was certain black mushrooms, which they call nanacatl, which intoxicate and cause visions to be seen, and even provoke”
W. E. Safford, Narcotic Plants and Stimulants of the Ancient Americans, “Lophophora Williamsii, the so-called sacred mushroom”, pp. 404–405. From the Smithsonian Report for 1916, pages 387–424 (Publication 2466). Washington: Government Printing Office, 1917. The text, read in part
Safford, having searched in vain for a fungus with the properties of teonanacatl, reports finding instead a narcotic plant with exactly its properties, one form of which, dried as a drug, looks so like a dried mushroom as to deceive a mycologist; in this section he identifies teonanacatl with Lophophora williamsii (peyote), his own identification, not the old writers'.
“No such fungus, however, was discovered, but in its place a narcotic plant having properties exactly like those attributed to the teonanacatl was encountered; moreover, one form of this plant, when prepared as a drug, resembles a dried mushroom so remarkably that at first glance it will even deceive a mycologist”
W. E. Safford, Narcotic Plants and Stimulants of the Ancient Americans, “Lophophora Williamsii, the so-called sacred mushroom”, p. 400. From the Smithsonian Report for 1916, pages 387–424 (Publication 2466). Washington: Government Printing Office, 1917. The text, read in part
Each passage is quoted from the text named, which the press fetched and read, and was checked word for word against a fresh copy of it; the link opens that copy. Passages are given as printed, without the editors’ footnote numbers, and with words broken across lines joined.
Pharmacognosy
- Constituents
- psilocybin ChEMBLa prodrug
- psilocin ChEMBLthe active form, a serotonin 2A agonist
- Mechanism
- Psilocin acts at the serotonin 2A receptors of the cortex.
- Checked against ChEMBL
- psilocybin: ChEMBL’s curated mechanism: agonist 5-hydroxytryptamine receptor 2A.
- Standing
- Illegal in most countries; in mid-2023 Australia became the first country to legalise psilocybin for depression at the national level, and phase III trials are under way.
- Griffiths, R. R., et al. (2006). Psychopharmacology 187. Abstract read · the text read
The abstract of each source, beneath its citation. For Club members. About the Club or sign in.
Constituent names open the compound’s record at PubChem, and “ChEMBL” beside a name opens its record at ChEMBL, the European Bioinformatics Institute’s database of bioactive molecules. Where a mechanism line was checked against ChEMBL (ChEMBL 37, read 1 October 2026), the check is shown with the measured value and its source paper, or says plainly that nothing has been measured. Doses are as the references give them, for description only; this is not medical advice. Each source carries the result of its check against Crossref, PubMed, or the authority’s page: see Verification.
Sources
- Sahagún, B. de. Historia general de las cosas de Nueva España, ed. C. M. de Bustamante, vol. 3. Mexico, 1830. Read in part · the text read
- Skalski, P., Pękacka-Falkowska, K., Pluto-Prądzyńska, A., and Owecki, M. K. (2026). Psilocybin in neuropsychiatric disorders: seeking valuable evidence in history, pure science, clinical trials and real-world data. Brain Sciences 16: 358. Read in part · the text read
- Luz, M. A., et al. (2025). Chemical composition and biological activities of Psilocybe mushrooms: gaps and perspectives. Pharmaceuticals 18: 989. Read in part · the text read
- Strauss, D., Ghosh, S., Murray, Z., and Gryzenhout, M. (2022). Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields. 3 Biotech 12: 339. Abstract read · the text read
- Goodwin, G. M., et al. (2022). Single-dose psilocybin for a treatment-resistant episode of major depression. New England Journal of Medicine. Abstract read · the text read
Verification
- Checked
- October 1, 2026, October 17, 2026
- Passes
- Read against its sources in the pass over the remaining 343 entries
- Every dated or regulatory claim checked by category across the database
- The mechanism read against ChEMBL (ChEMBL 37): curated mechanisms and measured activity
- Every source read, in full, in part, or in its abstract, and every sentence checked against what was read (October 17, 2026)
- Sources
- 6 cited: 3 read in part, 3 abstract read. 3 with the abstract on file.
- Corrections
- None recorded.
What was checked, how, and what was found is set out on the Verification page. A checked source is one whose record was found; it does not make the entry medical advice.
Club members can point at a technical term in this entry, such as a constituent, an action, or a word of Jung’s, to read its definition from the source. The Club.
Cite This Entry
Version 1 · first published September 25, 2026 · last revised October 17, 2026
- Chicago
“Teonanácatl.” In Materia Medica, edited by B. C. P. Statema. Version 1. The Thinking Press, 2026–. Last modified October 17, 2026. https://thethinkingpress.org/materia-medica/teonanacatl.
- MLA
“Teonanácatl.” Materia Medica, edited by B. C. P. Statema, version 1, The Thinking Press, 17 Oct. 2026, thethinkingpress.org/materia-medica/teonanacatl. Accessed 22 Nov. 2026.
- APA
Teonanácatl. (2026, October 17). In B. C. P. Statema (Ed.), Materia medica (Version 1). The Thinking Press. Retrieved November 22, 2026, from https://thethinkingpress.org/materia-medica/teonanacatl
See Also
Nearby in the alphabet
Terra sigillata (A clay dug on the island of Lemnos and stamped with a seal) · Teasel (Dipsacus fullonum) · Tetragrammaton (not pronounced in Jewish practice) · Tea tree oil · Theriac · Tea (The dried leaves of Camellia sinensis) · Thorn apple (of the nightshade family) · Tansy (Tanacetum vulgare)
Historical description, not medical advice.









